Abstract
Progestin supplementation appears to be a promising approach to both preventing initiation of pre-term labor and treating it once it is already established. Successful pregnancy depends on maternal tolerance of the fetal “semi-allograft”. A protein called progesterone-induced blocking factor (PIBF), by inducing a Th2 dominant cytokine production mediates the immunological effects of progesterone. Over time, various attempts have been made to clarify the question, whether progestogens can contribute positively to either prevention or treatment of pre-term labor and birth. Dydrogesterone treatment of women at risk of pre-term delivery results in increased PIBF production and IL-10 concentrations, and lower concentrations of IFNγ and could be effective for prevention or treatment of pre-term labor. Further randomized studies are needed.
Acknowledgments
This work was supported by SROP-4.2.2.A-11/1/KONV-2012-0053, SROP-4.2.2.D-15/1/KONV-2015-0004 and by PTE ÁOK-KA 2015-12.
Conflict of interest statement: The authors report no declaration of interest.
References
1. Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2009. Natl Vital Stat Rep 2010;59:1–19.Search in Google Scholar
2. Mathews TJ, MacDorman MF. Infant mortality statistics from the 2009 period linked birth/infant death data set. Natl Vital Stat Rep 2013;61:1–27.Search in Google Scholar
3. Iams JD, Berghella V. Care for women with prior preterm birth. Am J Obstet Gynecol 2010;203:89–100.10.1002/9781444317619.ch11Search in Google Scholar
4. Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH, Rubens C, Menon R, Van Look PF. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 2010;88:31–8.10.2471/BLT.08.062554Search in Google Scholar
5. Centers for Disease Control and Prevention, National Center for Health Statistic. Final natality data, Atlanta, GA, USA, 2008.Search in Google Scholar
6. Hudić I, Szekeres-Bartho J, Fatušić Z, Stray-Pedersen B, Dizdarević-Hudić L, Latifagić A, Hotić N, Kamerić L, Mandžić A. Dydrogesterone supplementation in women with threatened preterm delivery-the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor. J Reprod Immunol 2011;92:103–7.10.1016/j.jri.2011.08.006Search in Google Scholar
7. Szekeres-Bartho J, Barakonyi A, Par G, Polgar B, Palkovics T, Szereday L. Progesterone as an immunomodulatory molecule. Int Immunopharmacol 2001;1:1037–48.10.1016/S1567-5769(01)00035-2Search in Google Scholar
8. Szekeres-Bartho J, Barakonyi A, Polgar B, Par G, Faust Z, Palkovics T, Szereday L. The role of g/d T cells in progesterone-mediated immunomodulation during pregnancy: a review. Am J Reprod Immunol 1999;42:44–8.10.1111/j.1600-0897.1999.tb00464.xSearch in Google Scholar PubMed
9. Polgar B, Nagy E, Miko E, Varga P, Szekeres-Bartho J. Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome. Biol Reprod 2004;71:1699–705.10.1095/biolreprod.104.030437Search in Google Scholar PubMed
10. Szekeres-Bartho J, Kilar F, Faljay G, Csernus V, Torok A, Pacsa AS. Progesterone-treated lymphocytes of healthy pregnant women release a factor inhibiting cytotoxicity and prostaglandin syntesis. Am J Reprod Immunol Microbiol 1985;9:15–8.10.1111/j.1600-0897.1985.tb00334.xSearch in Google Scholar PubMed
11. Par G, Bartok B, Szekeres-Bartho J. Cyclooxygenase is involved in the effect of Progesterone induced blocking factor (PIBF) on IL-12 production. Am J Obstet Gynecol 2000;183:126–30.10.1067/mob.2000.105742Search in Google Scholar
12. Challis RG, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 2000;21:514–50.10.1210/edrv.21.5.0407Search in Google Scholar PubMed
13. Par G, Geli J, Kozma N, Varga P, Szekeres-Bartho J. Progesterone regulates IL12 expression in pregnancy lymphocytes by inhibiting phospholipase A2. Am J Reprod Immunol 2003;49:1–5.10.1034/j.1600-0897.2003.01149.xSearch in Google Scholar PubMed
14. Szekeres-Barthó J, Csernus V, Hadnagy J, Pacsa AS. Progesterone-prostaglandin balance influences lymphocyte function in relation to pregnancy. Am J Reprod Immunol 1983;4:139–41.10.1111/j.1600-0897.1983.tb00268.xSearch in Google Scholar PubMed
15. Szekeres-Bartho J, Hadnagy J, Pacsa AS. Immunologic factors contributing to the initiation of labor-lymphocyte reactivity in term labor and threatened preterm delivery. Am J Obstet Gynecol 1986;155:108–12.10.1016/0002-9378(86)90090-6Search in Google Scholar
16. Beta J, Szekeres-Bartho J, Skyfta E, Akolekar R, Nicolaides K. Maternal serum progesterone-induced blocking factor at 11–13 weeks’ gestation in spontaneous early preterm delivery. Fetal Diagn Ther 2011;29:197–200.10.1159/000322388Search in Google Scholar
17. Haluska J, Wells TR, Hirst JJ, Brenner RM, Sadowsky DW, Novy MJ. Progesterone receptor localization and isoforms in myometrium, decidua and fetal membranes from rhesus macaques: evidence of functional progesterone withdrawal at parturition. J Soc Gynecol Investig 2002;9: 125–36.10.1016/S1071-5576(02)00144-2Search in Google Scholar
18. Szekeres-Bartho J, Wegmann TG. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol 1996;31:81–95.10.1016/0165-0378(96)00964-3Search in Google Scholar
19. Hudić I, Fatušić Z, Szekeres-Bartho J, BalićD, Polgar B, Ljuca D, Dizdarević-Hudić L. Progesterone-induced blocking factor and cytokine profile in women with threatened pre-term delivery. Am J Reprod Immunol 2009;61:330–7.10.1111/j.1600-0897.2009.00699.xSearch in Google Scholar PubMed
20. Szekeres-Bartho J, Faust ZS, Varga P, Szereday L, Kelemen K. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol 1996;35:348–51.10.1111/j.1600-0897.1996.tb00492.xSearch in Google Scholar PubMed
21. Szekeres-Bartho J, Wilczynski JR, Basta P, Kalinka J. Role of progesterone and progestin therapy in threatened abortion and preterm labor. Front Biosci 2008;13:1981–90.10.2741/2817Search in Google Scholar PubMed
22. Schindler AE. Progestogens and pregnancy disorders. Giorn It Ost Gin 2015;37:35–7.Search in Google Scholar
23. Schindler AE. Role of progestogens for the prevention of premature birth. J Steroid Biochem Mol Biol 2005;97:435–8.10.1016/j.jsbmb.2005.08.008Search in Google Scholar PubMed
24. Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, Thijssen JH. Classification and pharmacology of progestins. Maturitas 2008;61:171–80.10.1016/j.maturitas.2003.09.014Search in Google Scholar PubMed
25. Lje SD, Porter DG. Demonstration that progesterone blocks uterine activity in the ewe in vivo by a direct action on the myometrium. J Reprod Fertil 1978;52:87–94.10.1530/jrf.0.0520087Search in Google Scholar PubMed
26. Puri CP, Garfield RE. Changes in hormone levels and gap junctions in the rat uterus during pregnancy and parturition. Biol Reprod 1982;27:967–75.10.1095/biolreprod27.4.967Search in Google Scholar PubMed
©2016 Walter de Gruyter GmbH, Berlin/Boston
